You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

blinatumomab

Showing 26 - 50 of 59
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Richter Syndrome Trial in France (RCHOP, Blinatumomab)

Active, not recruiting
  • Richter Syndrome
  • Amiens, France
  • +27 more
Jul 26, 2022

Philadelphia Chromosome-negative or BCR-ABL-negative, CD19-positive ALL Trial in Spain (blinatumomab)

Terminated
  • Philadelphia Chromosome-negative or BCR-ABL-negative, CD19-positive ALL
  • blinatumomab
  • Badalona, Barcelona, Spain
  • +11 more
Jul 26, 2022

Acute Lymphoblastic Leukemia Trial in Worldwide (Blinatumomab, AMG 404, Dexamethasone Premedication)

Active, not recruiting
  • Acute Lymphoblastic Leukemia
  • Blinatumomab
  • +2 more
  • Duarte, California
  • +18 more
Jul 27, 2022

B-cell Acute Lymphoblastic Leukemia Trial in Tampa, Durham, Winston-Salem (Blinatumomab)

Withdrawn
  • B-cell Acute Lymphoblastic Leukemia
  • Blinatumomab
  • Tampa, Florida
  • +2 more
Feb 14, 2022

ALL, Adult Trial in Belgium, Netherlands (Blinatumomab)

Active, not recruiting
  • ALL, Adult
  • Blinatumomab
  • Antwerpen, Belgium
  • +17 more
Dec 29, 2021

B-cell Acute Lymphoblastic Leukemia, B-cell Childhood Acute Lymphoblastic Leukemia, B-Cell ALL, Childhood Trial in Milwaukee

Recruiting
  • B-cell Acute Lymphoblastic Leukemia
  • +2 more
  • Alpha/Beta T-cell and B-cell depleted HCT
  • Blinatumomab
  • Milwaukee, Wisconsin
    Children's Hospital of Wisconsin
Sep 12, 2021

Acute Lymphoblastic Leukemia (ALL), Acute Myeloid Leukemia (AML), MDS (MDS) Trial in Memphis (drug, biological, device)

Recruiting
  • Acute Lymphoblastic Leukemia (ALL)
  • +7 more
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Oct 8, 2021

Refractory Acute Lymphoblastic Leukemia, Relapsed Acute Lymphoblastic Leukemia Trial in Memphis (drug, biological, radiation)

Not yet recruiting
  • Refractory Acute Lymphoblastic Leukemia
  • Relapsed Acute Lymphoblastic Leukemia
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Aug 23, 2022

Philadelphia-Negative ALL, High-Risk Cancer Trial in Israel (Blinatumomab)

Recruiting
  • Philadelphia-Negative ALL
  • High-Risk Cancer
  • Blinatumomab
  • Haifa, Israel
  • +3 more
May 6, 2021

Non-Hodgkin Lymphoma Trial in Boston (Blinatumomab)

Active, not recruiting
  • Non-Hodgkin Lymphoma
  • Blinatumomab
  • Boston, Massachusetts
    Massachusetts general Hospital
Jan 31, 2021

B Acute Lymphoblastic Leukemia Trial (procedure, biological, drug, radiation)

Not yet recruiting
  • B Acute Lymphoblastic Leukemia
  • Biospecimen Collection
  • +19 more
  • (no location specified)
Nov 8, 2023

Philadelphia Chromosome Negative, Recurrent B Acute Lymphoblastic Leukemia, Refractory B Acute Lymphoblastic Leukemia Trial in

Terminated
Has Results
  • Philadelphia Chromosome Negative
  • +2 more
  • Blinatumomab
  • +11 more
  • Houston, Texas
    M D Anderson Cancer Center
Nov 3, 2022

Leukemia, B-cell, Lymphoma, B-Cell Trial in Cincinnati (Blinatumomab, Pembrolizumab)

Withdrawn
  • Leukemia, B-cell
  • Lymphoma, B-Cell
  • Cincinnati, Ohio
    Cincinnati Children's Hospital Medical Center
Mar 30, 2021

Acute Lymphoblastic Leukemia, Adult Trial (Ponatinib, Blinatumomab, Imatinib)

Not yet recruiting
  • Acute Lymphoblastic Leukemia, Adult
  • (no location specified)
Dec 28, 2020

Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia With

Recruiting
  • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • +5 more
  • Blinatumomab
  • +8 more
  • Houston, Texas
    M D Anderson Cancer Center
Feb 1, 2022

Acute Lymphoblastic Leukemia Trial (Tisagenlecleucel, Blinatumomab, Inotuzumab)

Withdrawn
  • Acute Lymphoblastic Leukemia
  • Tisagenlecleucel
  • +2 more
  • (no location specified)
Jul 7, 2020

B-Cell Non Hodgkin Lymphoma Trial in Worldwide (Blinatumomab)

Completed
Has Results
  • B-Cell Non Hodgkin Lymphoma
  • Blinatumomab
  • Duarte, California
  • +30 more
Dec 18, 2020

Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia Trial in Worldwide (Blinatumomab, Standard of Care Chemotherapy)

Terminated
Has Results
  • Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia
  • Blinatumomab
  • Standard of Care Chemotherapy
  • Duarte, California
  • +116 more
Jan 4, 2022

Down Syndrome, Recurrent B Acute Lymphoblastic Leukemia Trial in Worldwide (radiation, biological, drug)

Suspended
  • Down Syndrome
  • Recurrent B Acute Lymphoblastic Leukemia
  • 3-Dimensional Conformal Radiation Therapy
  • +13 more
  • Birmingham, Alabama
  • +202 more
Jan 17, 2023

Acute Lymphoblastic Leukemia, Acute Lymphoblastic Lymphoma Trial in Australia, United States (Prednisone, Vincristine,

Recruiting
  • Acute Lymphoblastic Leukemia
  • Acute Lymphoblastic Lymphoma
  • Palo Alto, California
  • +6 more
May 2, 2022

Multiple Myeloma Trial in Philadelphia (Blinatumomab)

Terminated
  • Multiple Myeloma
  • Blinatumomab
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
Feb 5, 2020

High-risk Diffuse Large B-cell Lymphoma Trial in Worldwide (Blinatumomab)

Terminated
Has Results
  • High-risk Diffuse Large B-cell Lymphoma
  • Blinatumomab
  • Atlanta, Georgia
  • +31 more
Sep 10, 2020

Acute Lymphoblastic Leukemia, B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative Trial in Worldwide (procedure,

Active, not recruiting
  • Acute Lymphoblastic Leukemia
  • B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +15 more
  • Birmingham, Alabama
  • +550 more
Jan 28, 2023

High-risk DLBCL Trial in Worldwide (Blinatumomab, Investigator's Choice Chemotherapy, Dexamethasone)

Completed
Has Results
  • High-risk Diffuse Large B-Cell Lymphoma
  • Blinatumomab
  • +2 more
  • Chicago, Illinois
  • +23 more
Aug 26, 2020

Childhood Acute Lymphoblastic Leukemia Trial in Moscow, Saint Petersburg (Blinatumomab)

Recruiting
  • Childhood Acute Lymphoblastic Leukemia
  • Blinatumomab
  • Moscow, Russian Federation
  • +3 more
Jan 22, 2021